SAMP-ening down sepsis

Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA Correspondence to: Alison Coady, PhD. Division of Host-Microbe Systems & Therapeutics, University of California, San Diego, La Jolla, CA 920930760, USA. Email: [email protected]; Victor Nizet, MD. Division of Host-Microbe Systems & Therapeutics, University of California, San Diego, La Jolla, CA 92093-0760, USA. Email: [email protected]. Provenance: This is a Guest Editorial commissioned by the Section Editor Binrong Zhou, MD, PhD (Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China). Comment on: Spence S, Greene MK, Fay F, et al. Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. Sci Transl Med 2015;7:303ra140.